penis enlargement

Warning: DHT Blockers May Increase Prostate Cancer Risk

October 24, 2010

Are you taking DHT blockers to prevent hair loss? If so, you may be increasing your risk for developing prostate cancer, as well as sexual dysfunction.

A study by the Cochrane Review found that 5-alpha-reductase inhibitors—drugs and supplements that prevent the conversion of testosterone to dihydrotestosterone (DHT)—have inadequate evidence to say they reduce mortality, in terms of prostate cancer. While abnormally elevated levels of DHT may increase male patients’ risks of developing prostate cancer, a metabolite of DHT, 3-beta-adiol, may actually help prevent and reduce the grade of prostate cancers. The production of the this important metabolite, 3-beta-adiol, is reduced by 5-alpha-reductase inhibitors.

Some researchers in the Prostate Cancer Prevention Trial (PCPT), after reviewing the results of this 7 year study, feel that while DHT levels are important, levels of 3-beta-adiol are also important. Further, the clinical experience of Dr. Jonathan Wright, MD—the father of bio-identical hormone replacement therapy—have provided evidence that the ratio of DHT to 3-beta-adiol may be more important than the amount of DHT alone.

Read the full press release.